Join the Sleep Apnea group to help and get support from people like you.
Sleep Apnea News (Page 3)
Related terms: Sleep Apnoea
Bariatric Surgery Tied to Lower Risk of MACE, Death in Obesity, Sleep Apnea
FRIDAY, June 28, 2024 – Metabolic surgery is associated with significantly lower risk of major adverse cardiovascular events (MACE) compared with nonsurgical management among patients with...
ADA: Tirzepatide Reduces Apnea-Hypopnea Index in Moderate-to-Severe OSA
WEDNESDAY, June 26, 2024 – Tirzepatide reduces the apnea-hypopnea index (AHI) among individuals with moderate-to-severe obstructive sleep apnea and obesity, according to a study published online...
GLP-1 Medicine Mounjaro May Be First Drug to Ease Sleep Apnea
FRIDAY, June 21, 2024 – A medication used to manage type 2 diabetes has been found effective in treating sleep apnea. The worldwide clinical trial demonstrates that tirzepatide significantly lowers...
Sleep Apnea Could Mean More Hospitalizations
TUESDAY, June 4, 2024 – Folks with sleep apnea are more likely to require hospitalization for an ailment, a new study shows. People aged 50 and older with sleep apnea have 21% higher odds of...
Sleep Apnea Treatment Can Give Couples' Bond a Boost
MONDAY, June 3, 2024 – Strapping a mask to your face can make for a happier marriage, a new study suggests. Relationships with partners flourish if a person with sleep apnea starts using a...
Sleep Apnea Linked With Late-Life Epilepsy
THURSDAY, May 2, 2024 – Add one more damaging consequence of sleep apnea to the list: New research suggests it's related to late-life epilepsy. Late-onset epilepsy is defined as seizures that tend...
Sleep Apnea, Low Oxygen in Sleep Linked to Late-Onset Epilepsy
THURSDAY, May 2, 2024 – Sleep apnea and late-midlife oxygen desaturation to less than 80 percent during sleep are associated with subsequent development of late-onset epilepsy (LOE), according to a...
FDA Approves Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea
DUBLIN, March 20, 2019 /PRNewswire/ – Jazz Pharmaceuticals plc today announced that the U.S. Food and Drug Administration (FDA) approved Sunosi (solriamfetol) to improve wakefulness in adult...